Denmark remains a strong exporting nation, with pharma a central player
New export figures for November from Statistics Denmark show that medicine constitutes a significant part of total Danish exports with a value of 153.6 billion kroner ($21 billion) in the first 11 months of 2024, of which 14.2 billion kroner is in November.
"The pharmaceutical industry is a growth driver for the Danish economy, and it just shows why it is so important that we continue to focus on healthcare innovation and development in Denmark," says Ida Sofie Jensen, chief executive of pharma trade group.
"Over a number of years, Danish exports of medicine have been increasing, and this emphasizes the importance of cooperation between public and private companies on production, health and research," she noted.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
More on this story...
Today's issue
Company Spotlight
More Features in Pharmaceutical
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze